Smegenų aneurizmos fondas - Company finances
|
EUR
|
2021
From: 2021-04-26
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | 90,134 | 83,326 | 21,113 | 10,738 |
| Profit before tax | - | 0 | 0 | 0 | -2,545 |
| Net profit | - | 0 | 0 | 0 | -2,545 |
| Equity | 0 | 0 | 0 | 0 | -2,545 |
| Liabilities | 2,050 | 3,126 | 3,680 | 1,267 | 3,297 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 24,963 | 12,656 | 7,669 | 1,940 | 752 |
| Total assets | 24,963 | 12,656 | 7,669 | 1,940 | 752 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 6,820 | - | - |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | -7.6% | -74.7% | -49.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | 0.0% | 0.0% | 0.0% | -338.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 0.0% | 0.0% | 0.0% | -23.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 0.0% | 0.0% | 0.0% | -23.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 90,134 | 83,326 | 21,113 | 10,738 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Smegenų aneurizmos fondas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-06-17 | 2025-07-13 | 0.05 |
| 2025-05-16 | 2025-06-04 | 0.05 |
| 2025-05-04 | 2025-05-05 | 0.05 |
| 2025-04-24 | 2025-04-29 | 0.05 |
| 2025-03-18 | 2025-03-20 | 42.21 |
| 2024-08-19 | 2024-08-20 | 0.04 |
| 2024-07-24 | 2024-08-11 | 0.04 |
| 2024-06-18 | 2024-06-19 | 42.21 |
| 2024-02-19 | 2024-02-22 | 1.82 |
| 2023-11-16 | 2023-11-22 | 759.75 |
| 2022-08-23 | 2022-09-05 | 0.19 |
| 2022-07-25 | 2022-08-01 | 0.19 |
| 2022-03-16 | 2022-03-20 | 0.61 |
| 2022-02-17 | 2022-03-03 | 0.61 |
| 2022-01-28 | 2022-02-01 | 0.61 |
| 2021-12-16 | 2021-12-19 | 403.85 |
Smegenų aneurizmos fondas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-16 | 2025-03-20 | 0.6 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Smegenu aneurizmos fondas, VšI (code 305742357) is a Public Institution engaged in Activities of other membership organisations n.e.c. In the latest financial year, 2025, the company generated €10.7K in revenue and recorded a net loss of €2.5K, resulting in a profit margin of -23.7%. Revenue continued to decline, falling by 49.1% year on year in 2025 and by 87.1% over two years, from €83.3K in 2023 to €21.1K in 2024 and then to €10.7K in 2025. The balance sheet also contracted materially: total assets decreased from €7.7K in 2023 to €1.9K in 2024 and €752 in 2025, while liabilities were €3.3K at year-end 2025 after €3.7K in 2023 and €1.3K in 2024. Equity stood at -€2.5K in 2025, indicating a weakened capital position. Revenue per employee in 2025 was €10.7K, with profit per employee at -€2.5K.